2022. Surgical approach with vascular reconstruction after an objective response to neoadjuvant therapy with an EGFR tyrosine kinase inhibitor: clinical case. Voprosy onkologii. 67, 2 (May 2022), 278–281. DOI:https://doi.org/10.37469/0507-3758-2021-67-2-278-281.